{ "items": [ "\n\n
\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n26 May 2023
\n \n \n \nThe University of Oxford and Selvita (WSE: SLV), one of the largest contract research organisations in Europe, are collaborating on drug discovery in the area of Parkinson's disease
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n2 May 2023
\n \n \n \nTwo papers by early career researchers in our Oxford Epilepsy Research Group have been highlighted recently.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n20 April 2023
\n \n \n \nAnd the certainty of evidence supporting its use is low, say researchers
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n14 March 2023
\n \n \n \nThe new Cohort Catalogue will facilitate discovery of over 60 neurodegeneration research cohorts from 17 countries across Europe
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n\n \n\n\n
\n \n\n \n23 February 2023
\n \n \n \nOur researchers are tackling the devastating brain condition encephalitis.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n MRC BNDU\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n31 January 2023
\n \n \n \nThe first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their 'smart' bioelectronic implants.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n3 January 2023
\n \n \n \nNMDAR-antibody encephalitis is an autoimmune brain condition caused by patient\u2019s own antibodies that bind to NMDA (N-Methyl-D-Aspartate) receptors in the synapses between nerve cells.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Coronavirus\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n21 November 2022
\n \n \n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n10 November 2022
\n \n \n \nEstablishing preclinical models of Alzheimer\u2019s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer\u2019s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n27 September 2022
\n \n \n \nScientists have developed a new way to test the theory that active neurons can change what they signal in the world, rather than keeping a stable correspondence to things (such as a features of an object, or ideas).
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n \n \n Teaching\n \n \n\n \n\n\n
\n \n\n \n21 September 2022
\n \n \n \nMount Sinai Rehabilitation Hospital's Mandell Center for Multiple Sclerosis Care and Neuroscience Research welcomed University of Oxford partners in September. Stakeholders from University of Oxford and Quinnipiac University met to discuss ongoing research and future opportunities to develop a Mandell MS Center concept of care in the UK.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n11 August 2022
\n \n \n \nA drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND), according to a new study.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n8 August 2022
\n \n \n \nProfessor Chrystalina Antoniades explains how the COVID pandemic accelerated an innovation in one research project into Parkinson's Disease.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n24 June 2022
\n \n \n \nText by Ian Fyfe for 'Nature Reviews Neurology'
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n15 June 2022
\n \n \n \nOur researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord. This is helping them to understand an important mechanism underlying chronic pain in humans, and provides a new treatment target.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n13 June 2022
\n \n \n \nTwo recent papers show that studying lymph nodes reveals details of the mechanisms of autoimmunity.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n9 June 2022
\n \n \n \nHaving multiple conditions that affect the heart is linked to a greater risk of dementia than having high genetic risk, according to a large-scale new study.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n7 June 2022
\n \n \n \nThe 14th Quinquennial Myasthenia Gravis Federation of America International Conference was recently held in Miami with 450 delegates attending in person, including over 100 from industry.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Event\n \n \n\n \n\n\n
\n \n\n \n20 May 2022
\n \n \n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n16 May 2022
\n \n \n \nA new paper from researchers at the Department of Paediatrics and the Nuffield Department of Clinical Neurosciences has shown that fibroblasts in the thymus, often considered simply as dull \u201cstructural\u201d cells, are much more complex than previously thought.
\n \n\n \n \n